Literature DB >> 10078082

Differential effects of defibrillation on systemic and cardiac sympathetic activity.

F Bode1, U Wiegand, W Raasch, G Richardt, J Potratz.   

Abstract

OBJECTIVE: To assess the effect of defibrillation shocks on cardiac and circulating catecholamines.
DESIGN: Prospective examination of myocardial catecholamine balance during dc shock by simultaneous determination of arterial and coronary sinus plasma concentrations. Internal countershocks (10-34 J) were applied in 30 patients after initiation of ventricular fibrillation for a routine implantable cardioverter defibrillator test. Another 10 patients were externally cardioverted (50-360 J) for atrial fibrillation. MAIN OUTCOME MEASURES: Transcardiac noradrenaline, adrenaline, and lactate gradients immediately after the shock.
RESULTS: After internal shock, arterial noradrenaline increased from a mean (SD) of 263 (128) pg/ml at baseline to 370 (148) pg/ml (p = 0.001), while coronary sinus noradrenaline fell from 448 (292) to 363 (216) pg/ml (p = 0.01), reflecting a shift from cardiac net release to net uptake. After external shock delivery, there was a similar increase in arterial noradrenaline, from 260 (112) to 459 (200) pg/ml (p = 0.03), while coronary sinus noradrenaline remained unchanged. Systemic adrenaline increased 11-fold after external shock (p = 0.01), outlasting the threefold rise following internal shock (p = 0.001). In both groups, a negative transmyocardial adrenaline gradient at baseline decreased further, indicating enhanced myocardial uptake. Cardiac lactate production occurred after ventricular fibrillation and internal shock, but not after external cardioversion, so the neurohumoral changes resulted from the defibrillation process and not from alterations in oxidative metabolism.
CONCLUSIONS: A dc shock induces marked systemic sympathoadrenal and sympathoneuronal activation, but attenuates cardiac sympathetic activity. This might promote the transient myocardial depression observed after electrical discharge to the heart.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10078082      PMCID: PMC1728717          DOI: 10.1136/hrt.79.6.560

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  39 in total

1.  Oxidative metabolism and myocardial blood flow changes after transthoracic DC countershocks in dogs.

Authors:  T G Trouton; J D Allen; A A Adgey
Journal:  Eur Heart J       Date:  1992-10       Impact factor: 29.983

2.  Adrenergic effects on internal cardiac defibrillation threshold.

Authors:  M F Rattes; A D Sharma; G J Klein; T Szabo; D L Jones
Journal:  Am J Physiol       Date:  1987-09

Review 3.  Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions.

Authors:  M Esler; G Jennings; G Lambert; I Meredith; M Horne; G Eisenhofer
Journal:  Physiol Rev       Date:  1990-10       Impact factor: 37.312

4.  Conduction disturbances caused by high current density electric fields.

Authors:  S Yabe; W M Smith; J P Daubert; P D Wolf; D L Rollins; R E Ideker
Journal:  Circ Res       Date:  1990-05       Impact factor: 17.367

5.  Effect of selective A1 adenosine receptor antagonism of postdefibrillation cardiovascular depression: evidence for an antiadrenergic role of endogenous adenosine.

Authors:  R C Wesley; D Porzio; M Sadeghi
Journal:  Cardiovasc Res       Date:  1993-01       Impact factor: 10.787

6.  Epinephrine release from the heart during left stellate ganglion stimulation in dogs.

Authors:  F Péronnet; R Nadeau; G Boudreau; R Cardinal; D Lamontagne; N Yamaguchi; J De Champlain
Journal:  Am J Physiol       Date:  1988-04

7.  Systemic and cardiac catecholamines during elective PTCA and during immediate PTCA for acute myocardial infarction.

Authors:  G Richardt; G Münch; F J Neumann; B Rauch; T Kurz
Journal:  Basic Res Cardiol       Date:  1997-02       Impact factor: 17.165

8.  Effects of defibrillation shocks delivered directly over a major coronary artery.

Authors:  S D Lucy; D L Jones; G J Klein
Journal:  Pacing Clin Electrophysiol       Date:  1992-11       Impact factor: 1.976

9.  Cardiac outflow of endothelin, neuropeptide Y and noradrenaline in relation to hyperaemia in coronary sinus flow following electrical conversion of induced ventricular fibrillation in man.

Authors:  M Runsiö; M Rosenqvist; L Bergfeldt; A Owall; J M Lundberg; A Franco-Cereceda
Journal:  Eur Heart J       Date:  1995-12       Impact factor: 29.983

10.  Catecholamine response to laryngoscopy and intubation. The influence of three different drug combinations commonly used for induction of anaesthesia.

Authors:  B Chraemmer-Jørgensen; S Hertel; J Strøm; P F Høilund-Carlsen; K Bjerre-Jepsen
Journal:  Anaesthesia       Date:  1992-09       Impact factor: 6.955

View more
  5 in total

1.  Predictive value of heart rate variability for the recurrence of chronic atrial fibrillation after electrical cardioversion.

Authors:  Omer Akyürek; Erdem Diker; Muharrem Güldal; Derviş Oral
Journal:  Clin Cardiol       Date:  2003-04       Impact factor: 2.882

2.  Increased Platelet-to-Lymphocyte Ratios and Low Relative Lymphocyte Counts Predict Appropriate Shocks in Heart Failure Patients with ICDs.

Authors:  Kevser Gülcihan Balci; Mustafa Mücahit Balci; Ugur Arslan; Burak Açar; Orhan Maden; Hatice Selcuk; Timur Selcuk
Journal:  Acta Cardiol Sin       Date:  2016-09       Impact factor: 2.672

3.  Not just any ICD device in patients with long-QT syndrome.

Authors:  E O Udo; H F Baars; J B Winter; A A M Wilde
Journal:  Neth Heart J       Date:  2007-12       Impact factor: 2.380

4.  Electrical storm: mechanistic and therapeutic considerations to avoid death in the survivors.

Authors:  Yukiomi Tsuji; Dobromir Dobrev
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 3.005

Review 5.  Expert consensus on acute management of ventricular arrhythmias - VT network Austria.

Authors:  M Martinek; M Manninger; R Schönbauer; D Scherr; C Schukro; H Pürerfellner; A Petzl; B Strohmer; M Derndorfer; E Bisping; M Stühlinger; L Fiedler
Journal:  Int J Cardiol Heart Vasc       Date:  2021-04-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.